These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Differential effect of cancer on the serum protein binding to mianserin and imipramine. Torres I, Suárez E, Rodríguez-Sasiain JM, Aguirre C, Calvo R. Eur J Drug Metab Pharmacokinet; 1995 May; 20(2):107-11. PubMed ID: 8582434 [Abstract] [Full Text] [Related]
10. Rapid microsample analysis of imipramine and desipramine by reversed-phase high-performance liquid chromatography with ultraviolet detection. Yoo SD, Holladay JW, Fincher TK, Dewey MJ. J Chromatogr B Biomed Appl; 1995 Jun 23; 668(2):338-42. PubMed ID: 7581871 [Abstract] [Full Text] [Related]
12. Alterations induced in distribution and in vivo metabolism of imipramine by pregnenolone-16alpha-carbonitrile. Brookman S, Kourounakis P. J Pharm Sci; 1977 Oct 23; 66(10):1492-4. PubMed ID: 925914 [Abstract] [Full Text] [Related]
19. Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages. Daniel W, Adamus A, Melzacka M, Szymura J, Vetulani J. Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov 23; 317(3):209-13. PubMed ID: 7322212 [Abstract] [Full Text] [Related]
20. Monitoring of serum levels of imipramine and desipramine and individualization of dose in enuretic children. de Gatta MF, García MJ, Acosta A, Rey F, Gutierrez JR, Dominguez-Gil A. Ther Drug Monit; 1984 Nov 23; 6(4):438-43. PubMed ID: 6515703 [Abstract] [Full Text] [Related] Page: [Next] [New Search]